All In Biotech

Drug Trial Radar · NCT07345689

A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations

A Study to Evaluate the Pharmacokinetics and Safety of Anaprazole Sodium in Subjects With Hepatic or Renal Impairment and in Elderly Subjects

Last checked: Nov 19, 2026Latest source record: Jan 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Jan 30, 2026

Primary completion

Oct 30, 2026

Study completion Jun 30, 2027

Sponsor

Sponsor type
Industry
First posted
Jan 16, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the pharmacokinetic profile and safety of anaprazole sodium in adult subjects, particularly including the elderly and those with renal or hepatic impairment.

Conditions

  • Hepatic Insufficiency
  • Renal Insufficiency
  • Elderly

Interventions

  • Anaprazole Sodium enteric-coated tabletDrug

    20 mg single dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. CmaxTime frame: Up to 48 hours from anaprazole sodium administration
  2. TmaxTime frame: Up to 48 hours from anaprazole sodium administration
  3. AUC0-tTime frame: Up to 48 hours from anaprazole sodium administration
  4. AUC0-∞Time frame: Up to 48 hours from anaprazole sodium administration
  5. t1/2Time frame: Up to 48 hours from anaprazole sodium administration
  6. CL/FTime frame: Up to 48 hours from anaprazole sodium administration
  7. Vz/FTime frame: Up to 48 hours from anaprazole sodium administration

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Bethune Hospital of Jilin University

    Changchun, Jilin, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.